TY - JOUR AU - Cooperberg, M. R. AU - Broering, J. M. AU - Carroll, P. R. PY - 2009 DA - 2009// TI - Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis JO - JNCI J Natl Cancer Inst VL - 101 UR - https://doi.org/10.1093/jnci/djp122 DO - 10.1093/jnci/djp122 ID - Cooperberg2009 ER - TY - JOUR AU - Pishgar, F. AU - Ebrahimi, H. AU - Moghaddam, S. S. AU - Fitzmaurice, C. AU - Amini, E. PY - 2018 DA - 2018// TI - Global, Regional and National Burden of Prostate Cancer, 1990–2015: Results from the global burden of disease study 2015 JO - J Urol VL - 199 UR - https://doi.org/10.1016/j.juro.2017.10.044 DO - 10.1016/j.juro.2017.10.044 ID - Pishgar2018 ER - TY - JOUR AU - de Koning, H. J. AU - Gulati, R. AU - Moss, S. M. AU - Hugosson, J. AU - Pinsky, P. F. AU - Berg, C. D. PY - 2018 DA - 2018// TI - The efficacy of prostate-specific antigen screening: impact of key components in the ERSPC and PLCO trials JO - Cancer VL - 124 UR - https://doi.org/10.1002/cncr.31178 DO - 10.1002/cncr.31178 ID - de Koning2018 ER - TY - JOUR AU - Draisma, G. AU - Boer, R. AU - Otto, S. J. AU - van der Cruijsen, I. W. AU - Damhuis, R. A. M. AU - Schröder, F. H. PY - 2003 DA - 2003// TI - Lead times and overdetection due to prostate-specific antigen screening: estimates from the European randomized study of screening for prostate Cancer JO - J Natl Cancer Inst VL - 95 UR - https://doi.org/10.1093/jnci/95.12.868 DO - 10.1093/jnci/95.12.868 ID - Draisma2003 ER - TY - JOUR AU - Finne, P. AU - Fallah, M. AU - Hakama, M. AU - Ciatto, S. AU - Hugosson, J. AU - de Koning, H. PY - 2010 DA - 2010// TI - Lead-time in the European randomised study of screening for prostate cancer JO - Eur J Cancer VL - 46 UR - https://doi.org/10.1016/j.ejca.2010.09.034 DO - 10.1016/j.ejca.2010.09.034 ID - Finne2010 ER - TY - JOUR AU - Hayes, J. H. AU - Barry, M. J. PY - 2014 DA - 2014// TI - Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence JO - JAMA VL - 311 UR - https://doi.org/10.1001/jama.2014.2085 DO - 10.1001/jama.2014.2085 ID - Hayes2014 ER - TY - JOUR AU - Schröder, F. H. AU - Hugosson, J. AU - Roobol, M. J. AU - Tammela, T. L. J. AU - Zappa, M. AU - Nelen, V. PY - 2014 DA - 2014// TI - Screening and prostate cancer mortality: results of the European randomised study of screening for prostate cancer (ERSPC) at 13 years of follow-up JO - Lancet VL - 384 UR - https://doi.org/10.1016/S0140-6736(14)60525-0 DO - 10.1016/S0140-6736(14)60525-0 ID - Schröder2014 ER - TY - JOUR AU - Hamdy, F. C. AU - Donovan, J. L. AU - Lane, J. A. AU - Mason, M. AU - Metcalfe, C. AU - Holding, P. PY - 2016 DA - 2016// TI - 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer JO - N Engl J Med VL - 375 UR - https://doi.org/10.1056/NEJMoa1606220 DO - 10.1056/NEJMoa1606220 ID - Hamdy2016 ER - TY - JOUR AU - Gulati, R. AU - Inoue, L. Y. T. AU - Gore, J. L. AU - Katcher, J. AU - Etzioni, R. PY - 2014 DA - 2014// TI - Individualized estimates of overdiagnosis in screen-detected prostate cancer JO - J Natl Cancer Inst VL - 106 UR - https://doi.org/10.1093/jnci/djt367 DO - 10.1093/jnci/djt367 ID - Gulati2014 ER - TY - JOUR AU - Loeb, S. AU - Bjurlin, M. AU - Nicholson, J. AU - Tammela, T. L. AU - Penson, D. AU - Carter, H. B. PY - 2014 DA - 2014// TI - Overdiagnosis and overtreatment of prostate cancer JO - Eur Urol VL - 65 UR - https://doi.org/10.1016/j.eururo.2013.12.062 DO - 10.1016/j.eururo.2013.12.062 ID - Loeb2014 ER - TY - JOUR AU - Chang, A. J. AU - Autio, K. A. AU - Roach, M. AU - Scher, H. I. PY - 2014 DA - 2014// TI - “High-risk” prostate cancer: classification and therapy JO - Nat Rev Clin Oncol VL - 11 UR - https://doi.org/10.1038/nrclinonc.2014.68 DO - 10.1038/nrclinonc.2014.68 ID - Chang2014 ER - TY - JOUR AU - Carlsson, S. AU - Assel, M. AU - Sjoberg, D. AU - Ulmert, D. AU - Hugosson, J. AU - Lilja, H. PY - 2014 DA - 2014// TI - Influence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening: population based cohort study JO - BMJ VL - g2296 ID - Carlsson2014 ER - TY - JOUR AU - Carlsson, S. V. AU - Roobol, M. J. PY - 2017 DA - 2017// TI - Improving the evaluation and diagnosis of clinically significant prostate cancer in 2017 JO - Curr Opin Urol VL - 27 UR - https://doi.org/10.1097/MOU.0000000000000382 DO - 10.1097/MOU.0000000000000382 ID - Carlsson2017 ER - TY - JOUR AU - Cuzick, J. AU - Stone, S. AU - Fisher, G. AU - Yang, Z. H. AU - North, B. V. AU - Berney, D. M. PY - 2015 DA - 2015// TI - Validation of an RNA cell cycle progression score for predicting death from prostate cancer in a conservatively managed needle biopsy cohort JO - Br J Cancer VL - 113 UR - https://doi.org/10.1038/bjc.2015.223 DO - 10.1038/bjc.2015.223 ID - Cuzick2015 ER - TY - JOUR AU - Hendriks, R. J. AU - van der Leest, M. M. G. AU - Dijkstra, S. AU - Barentsz, J. O. AU - Van Criekinge, W. AU - Hulsbergen-van de Kaa, C. A. PY - 2017 DA - 2017// TI - A urinary biomarker-based risk score correlates with multiparametric MRI for prostate cancer detection JO - Prostate VL - 77 UR - https://doi.org/10.1002/pros.23401 DO - 10.1002/pros.23401 ID - Hendriks2017 ER - TY - JOUR AU - Klein, E. A. AU - Cooperberg, M. R. AU - Magi-Galluzzi, C. AU - Simko, J. P. AU - Falzarano, S. M. AU - Maddala, T. PY - 2014 DA - 2014// TI - A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling JO - Eur Urol VL - 66 UR - https://doi.org/10.1016/j.eururo.2014.05.004 DO - 10.1016/j.eururo.2014.05.004 ID - Klein2014 ER - TY - JOUR AU - Kretschmer, A. AU - Tilki, D. PY - 2017 DA - 2017// TI - Biomarkers in prostate cancer - current clinical utility and future perspectives JO - Crit Rev Oncol Hematol VL - 120 UR - https://doi.org/10.1016/j.critrevonc.2017.11.007 DO - 10.1016/j.critrevonc.2017.11.007 ID - Kretschmer2017 ER - TY - JOUR AU - McKiernan, J. AU - Donovan, M. J. AU - O’Neill, V. AU - Bentink, S. AU - Noerholm, M. AU - Belzer, S. PY - 2016 DA - 2016// TI - A novel urine exosome gene expression assay to predict high-grade prostate cancer at initial biopsy JO - JAMA Oncol VL - 2 UR - https://doi.org/10.1001/jamaoncol.2016.0097 DO - 10.1001/jamaoncol.2016.0097 ID - McKiernan2016 ER - TY - JOUR AU - Garisto, J. D. AU - Klotz, L. PY - 2017 DA - 2017// TI - Active surveillance for prostate cancer: how to do it right JO - Oncol (Williston Park) VL - 31 ID - Garisto2017 ER - TY - JOUR AU - Klotz, L. PY - 2017 DA - 2017// TI - Active surveillance for low-risk prostate cancer JO - Curr Opin Urol VL - 27 UR - https://doi.org/10.1097/MOU.0000000000000393 DO - 10.1097/MOU.0000000000000393 ID - Klotz2017 ER - TY - JOUR AU - Romero-Otero, J. AU - Garcia-Gómez, B. AU - Duarte-Ojeda, J. M. AU - Rodriguez-Antolín, A. AU - Vilaseca, A. AU - Carlsson, S. V. PY - 2016 DA - 2016// TI - Active surveillance for prostate cancer JO - Int J Urol VL - 23 UR - https://doi.org/10.1111/iju.13016 DO - 10.1111/iju.13016 ID - Romero-Otero2016 ER - TY - JOUR AU - Saad, F. PY - 2015 DA - 2015// TI - Active surveillance in prostate cancer: how far should we go? JO - JAMA Oncol VL - 1 UR - https://doi.org/10.1001/jamaoncol.2015.103 DO - 10.1001/jamaoncol.2015.103 ID - Saad2015 ER - TY - JOUR AU - Cree, I. A. AU - Uttley, L. AU - Buckley Woods, H. AU - Kikuchi, H. AU - Reiman, A. AU - Harnan, S. PY - 2017 DA - 2017// TI - The evidence base for circulating tumour DNA blood-based biomarkers for the early detection of cancer: a systematic mapping review JO - BMC Cancer VL - 17 UR - https://doi.org/10.1186/s12885-017-3693-7 DO - 10.1186/s12885-017-3693-7 ID - Cree2017 ER - TY - JOUR AU - Leygo, C. AU - Williams, M. AU - Jin, H. C. AU - Chan, M. W. Y. AU - Chu, W. K. AU - Grusch, M. PY - 2017 DA - 2017// TI - DNA methylation as a noninvasive epigenetic biomarker for the detection of cancer JO - Dis Markers VL - 3726595 ID - Leygo2017 ER - TY - JOUR AU - Payne, S. R. AU - Serth, J. AU - Schostak, M. AU - Kamradt, J. AU - Strauss, A. AU - Thelen, P. PY - 2009 DA - 2009// TI - DNA methylation biomarkers of prostate cancer: confirmation of candidates and evidence urine is the most sensitive body fluid for non-invasive detection JO - Prostate VL - 69 UR - https://doi.org/10.1002/pros.20967 DO - 10.1002/pros.20967 ID - Payne2009 ER - TY - JOUR AU - Wu, T. AU - Giovannucci, E. AU - Welge, J. AU - Mallick, P. AU - Tang, W. -. Y. AU - Ho, S. -. M. PY - 2011 DA - 2011// TI - Measurement of GSTP1 promoter methylation in body fluids may complement PSA screening: a meta-analysis JO - Br J Cancer VL - 105 UR - https://doi.org/10.1038/bjc.2011.143 DO - 10.1038/bjc.2011.143 ID - Wu2011 ER - TY - JOUR AU - Blute, M. L. AU - Damaschke, N. A. AU - Jarrard, D. F. PY - 2015 DA - 2015// TI - The epigenetics of PCA diagnosis and prognosis: update on clinical applications JO - Curr Opin Urol VL - 25 UR - https://doi.org/10.1097/MOU.0000000000000132 DO - 10.1097/MOU.0000000000000132 ID - Blute2015 ER - TY - JOUR AU - Geybels, M. S. AU - Wright, J. L. AU - Bibikova, M. AU - Klotzle, B. AU - Fan, J. -. B. AU - Zhao, S. PY - 2016 DA - 2016// TI - Epigenetic signature of Gleason score and prostate cancer recurrence after radical prostatectomy JO - Clin Epigenetics VL - 8 UR - https://doi.org/10.1186/s13148-016-0260-z DO - 10.1186/s13148-016-0260-z ID - Geybels2016 ER - TY - JOUR AU - Baden, J. AU - Adams, S. AU - Astacio, T. AU - Jones, J. AU - Markiewicz, J. AU - Painter, J. PY - 2011 DA - 2011// TI - Predicting prostate biopsy result in men with prostate specific antigen 2.0 to 10.0 ng/ml using an investigational prostate cancer methylation assay JO - J Urol VL - 186 UR - https://doi.org/10.1016/j.juro.2011.06.052 DO - 10.1016/j.juro.2011.06.052 ID - Baden2011 ER - TY - JOUR AU - Baden, J. AU - Green, G. AU - Painter, J. AU - Curtin, K. AU - Markiewicz, J. AU - Jones, J. PY - 2009 DA - 2009// TI - Multicenter evaluation of an investigational prostate cancer methylation assay JO - J Urol VL - 182 UR - https://doi.org/10.1016/j.juro.2009.05.003 DO - 10.1016/j.juro.2009.05.003 ID - Baden2009 ER - TY - JOUR AU - Enokida, H. AU - Shiina, H. AU - Urakami, S. AU - Igawa, M. AU - Ogishima, T. AU - Li, L. -. C. PY - 2005 DA - 2005// TI - Multigene methylation analysis for detection and staging of prostate cancer JO - Clin Cancer Res VL - 11 UR - https://doi.org/10.1158/1078-0432.CCR-05-0658 DO - 10.1158/1078-0432.CCR-05-0658 ID - Enokida2005 ER - TY - JOUR AU - Gonzalgo, M. L. AU - Pavlovich, C. P. AU - Lee, S. M. AU - Nelson, W. G. PY - 2003 DA - 2003// TI - Prostate cancer detection by GSTP1 methylation analysis of postbiopsy urine specimens JO - Clin Cancer Res VL - 9 ID - Gonzalgo2003 ER - TY - JOUR AU - Brikun, I. AU - Nusskern, D. AU - Gillen, D. AU - Lynn, A. AU - Murtagh, D. AU - Feczko, J. PY - 2014 DA - 2014// TI - A panel of DNA methylation markers reveals extensive methylation in histologically benign prostate biopsy cores from cancer patients JO - Biomark Res VL - 2 UR - https://doi.org/10.1186/s40364-014-0025-9 DO - 10.1186/s40364-014-0025-9 ID - Brikun2014 ER - TY - JOUR AU - Djavan, B. AU - Ravery, V. AU - Zlotta, A. AU - Dobronski, P. AU - Dobrovits, M. AU - Fakhari, M. PY - 2001 DA - 2001// TI - Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop? JO - J Urol VL - 166 UR - https://doi.org/10.1016/S0022-5347(05)65652-2 DO - 10.1016/S0022-5347(05)65652-2 ID - Djavan2001 ER - TY - JOUR AU - Djavan, B. AU - Mazal, P. AU - Zlotta, A. AU - Wammack, R. AU - Ravery, V. AU - Remzi, M. PY - 2001 DA - 2001// TI - Pathological features of prostate cancer detected on initial and repeat prostate biopsy: results of the prospective European prostate cancer detection study JO - Prostate VL - 47 UR - https://doi.org/10.1002/pros.1053 DO - 10.1002/pros.1053 ID - Djavan2001 ER - TY - JOUR AU - Geybels, M. S. AU - Zhao, S. AU - Wong, C. -. J. AU - Bibikova, M. AU - Klotzle, B. AU - Wu, M. PY - 2015 DA - 2015// TI - Epigenomic profiling of DNA methylation in paired prostate cancer versus adjacent benign tissue JO - Prostate VL - 75 UR - https://doi.org/10.1002/pros.23093 DO - 10.1002/pros.23093 ID - Geybels2015 ER - TY - JOUR AU - Haldrup, C. AU - Mundbjerg, K. AU - Vestergaard, E. M. AU - Lamy, P. AU - Wild, P. AU - Schulz, W. A. PY - 2013 DA - 2013// TI - DNA methylation signatures for prediction of biochemical recurrence after radical prostatectomy of clinically localized prostate cancer JO - J Clin Oncol VL - 31 UR - https://doi.org/10.1200/JCO.2012.47.1847 DO - 10.1200/JCO.2012.47.1847 ID - Haldrup2013 ER - TY - JOUR AU - Stott-Miller, M. AU - Zhao, S. AU - Wright, J. L. AU - Kolb, S. AU - Bibikova, M. AU - Klotzle, B. PY - 2014 DA - 2014// TI - Validation study of genes with hypermethylated promoter regions associated with prostate cancer recurrence JO - Cancer Epidemiol Biomark Prev VL - 23 UR - https://doi.org/10.1158/1055-9965.EPI-13-1000 DO - 10.1158/1055-9965.EPI-13-1000 ID - Stott-Miller2014 ER - TY - JOUR AU - Friedman, J. AU - Hastie, T. AU - Tibshirani, R. PY - 2000 DA - 2000// TI - Additive logistic regression: a statistical view of boosting (with discussion and a rejoinder by the authors) JO - Ann Stat VL - 28 UR - https://doi.org/10.1214/aos/1016218223 DO - 10.1214/aos/1016218223 ID - Friedman2000 ER - TY - JOUR AU - Zou, H. AU - Hastie, T. PY - 2005 DA - 2005// TI - Regularization and variable selection via the elastic net JO - J R Stat Soc Ser B Stat Methodol VL - 67 UR - https://doi.org/10.1111/j.1467-9868.2005.00503.x DO - 10.1111/j.1467-9868.2005.00503.x ID - Zou2005 ER - TY - BOOK AU - Zhou, X. AU - Obuchowski, N. AU - McClish, D. PY - 2011 DA - 2011// TI - Statistical methods in diagnostic medicine. Wiley Series in Probability and Statistics PB - Wiley CY - Hoboken UR - https://doi.org/10.1002/9780470906514 DO - 10.1002/9780470906514 ID - Zhou2011 ER -